نتایج جستجو برای: idarubicin

تعداد نتایج: 767  

2012
Dhara A. Patel Anand C. Patel William C. Nolan Yong Zhang Michael J. Holtzman

Most of current strategies for antiviral therapeutics target the virus specifically and directly, but an alternative approach to drug discovery might be to enhance the immune response to a broad range of viruses. Based on clinical observation in humans and successful genetic strategies in experimental models, we reasoned that an improved interferon (IFN) signaling system might better protect ag...

Journal: :American journal of hematology 2015
Mazyar Shadman Raya Mawad Carol Dean Tara L Chen Kathleen Shannon-Dorcy Vicky Sandhu Paul C Hendrie Bart L Scott Rol B Walter Pamela S Becker John M Pagel Elihu H Estey

Previous studies suggest that idarubicin/cytarabine(ara-C)/pravastatin (IAP) is an active salvage regimen for patients with AML. We therefore investigated this regimen in patients with newly-diagnosed AML or MDS (≥10% blasts). Patients were eligible if the anticipated treatment-related mortality (TRM) was <10%. Patients received pravastatin (1,280 mg/day po; days 1-8), cytarabine (1.5 g/m(2) /d...

2013
Burak UZ Eylem Eliaçık Ayse Işık Salih Aksu Yahya Büyükaşık İbrahim C. Haznedaroğlu Hakan Göker Nilgün Sayınalp Osman İ. Özcebe

UNLABELLED Additional chromosomal abnormalities in acute myelogenous leukemia have been identified as one of the most important prognostic factors. Favorable chromosomal changes such as t(8;21), inv(16), and t(15;17) are associated with higher rates of complete remission and event-free survival. Translocation (15;17) characterizes acute promyelocytic leukemia (APL) (French-American-British clas...

Journal: :Cancer research 2003
Luther Swift Jane McHowat Narine Sarvazyan

Administration of anthracyclines, a family of highly effective anticancer drugs, is associated with a cumulative dose-related cardiomyopathy, the etiology of which remains poorly understood. We have discovered that administration of the anthracyclines leads to a marked inhibition of membrane-associated calcium-independent phospholipase A(2) (iPLA(2)) both in vitro and in vivo. To elucidate the ...

Journal: :Molecular pharmacology 1997
M Binaschi G Capranico L Dal Bo F Zunino

The role of the site selectivity of topoisomerase II poisoning in the cytotoxic activity of anthracyclines has not been established. In this article, we have thus studied the levels and persistence of double-stranded DNA breaks (DSB) along with the cytotoxic activity in human leukemic HL60 cells of seven anthracyclines, including doxorubicin, daunorubicin, and idarubicin, as well as sugar-modif...

Journal: :Clinical chemistry 2008
Masato Mitsuhashi Katsuya Endo Kazuhiko Obara Hiroshi Izutsu Taishi Ishida Norio Chikatsu Atsushi Shinagawa

BACKGROUND In conventional bioassays, isolated cells are suspended in culture media, incubated in vitro for several days, and then characterized with respect to any cellular changes. In developing new molecular tests under physiological ex vivo conditions, we quantified the production of mRNAs for p21 and PUMA (p53 up-regulated modulator of apoptosis), which are involved in cell cycle arrest an...

2015
Wei Zhang Jing Wang Yanfang Wang Fei Dong Mingxia Zhu Wenli Wan Haishen Li Feifei Wu Xinxing Yan Xiaoyan Ke

BACKGROUND The role of B7-H3 in acute monocytic leukemia U937 cells has not been thoroughly investigated. MATERIALS AND METHODS B7-H3 knockdown in the U937 cell line was performed using small hairpin (sh)RNA lentivirus transduction. The effects on cell proliferation, cycle, migration, and invasion were investigated by Cell Counting Kit-8 assay, methyl cellulose colony-forming assay, propidium...

2017
Jae-Ho Yoon Hee-Je Kim Dae-Hun Kwak Gi June Min Sung-Soo Park Young-Woo Jeon Sung-Eun Lee Byung-Sik Cho Ki-Seong Eom Yoo-Jin Kim Seok Lee Chang-Ki Min Seok-Goo Cho Dong-Wook Kim Jong Wook Lee Woo-Sung Min

BACKGROUND Standard remission induction chemotherapy consisting of anthracycline plus cytarabine (3+7) is administered for adult acute myeloid leukemia (AML). However, the effects of intensified regimen on complete remission (CR), relapse and overall survival (OS) remain unknown. METHODS We analyzed 1195 patients treated with idarubicin plus cytarabine/BHAC (3+7) from 2002 to 2013. Among them...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید